A planned oral antimalarial product category within Esoma's future portfolio.
Active ingredient, strength, indication, dosage, contraindications and other clinical information will be based on the final approved product.
For wholesale, distribution, partnership or product-development enquiries, contact the Esoma team.
Once the final formulation, packaging and regulatory documentation are established, this page can be expanded with approved product specifications, pack sizes, storage information and professional product documentation.
